Three-fourths of patients have 70-75% improvement at 16 weeks with zasocitinib, envudeucit ...

Discover 8 pharmacist-approved natural remedies to soothe itchy skin, eczema, and psoriasis. Plus, learn which common ...

That trade-off may soon change. New clinical trial data suggests a once-daily pill called zasocitinib may provide the clear ...

CHICAGO, IL, UNITED STATES, March 30, 2026 /EINPresswire.com/ -- The National Psoriasis Foundation (NPF) welcomed more ...

What Alumis’ Phase 3 psoriasis data means for ALMS stock Alumis (ALMS) has put envudeucitinib at the center of the story after releasing Phase 3 ONWARD1 and ONWARD2 data in moderate to severe plaque ...

Nonsteroidal topicals like roflumilast are enabling proactive, long-term psoriasis control across a broad range of patients, ...

A TYK2 inhibitor in development shows superior efficacy to placebo and apremilast for treating psoriasis, with no new safety ...

"I was very ashamed. I felt like everywhere people were judging me," Amber Dean tells PEOPLE, recalling when her symptoms were at their worst ...

With the caveat that cross-trial comparisons can be unreliable, zasocitinib appears to have an advantage over Sotyktu. BMS reported PASI 90 rates of 32% to 42% and PASI 100 rates of 10% to 14% in its ...

Combining traditional dermatopathology with PCR-based molecular testing improves diagnostic accuracy in differentiating ...

"Walking around with this very visible, very robust ailment has a pretty tremendous impact on your mental health," Maddox ...